$GALT
Galectin Therapeutics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Norcross, GA
GALT chart
What traders are saying about $GALT
Latest postsGalectin Therapeutics Inc news
- Galectin Therapeutics Stock Price Forecast. Should You Buy GALT?
StockInvest.us ·
- Galectin Therapeutics (NASDAQ:GALT) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened
MarketBeat ·
- Galectin Therapeutics to present NASH cirrhosis trial data at AASLD
Investing.com ·
- Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026
Yahoo Finance ·
- A liver drug was linked to fewer swollen veins across risk groups
Stock Titan ·
- Galectin Therapeutics stock: AASLD presentations spotlight belapectin
ad-hoc-news.de ·
- Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
Yahoo Finance ·
- Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight
Yahoo Finance ·
- Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
Yahoo Finance ·
- GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial
stocktwits.com ·
Galectin Therapeutics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$30.8M | -$47.0M | -$41.1M | -$38.8M |
| Diluted EPS | $-0.48 | $-0.76 | $-0.74 | $-0.65 |
| Total assets (year end) | $19.5M | $17.5M | $28.2M | $21.3M |
| Cash and equivalents (year end) | $17.7M | $15.1M | $25.7M | $18.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Galectin Therapeutics Inc
- Ticker
- GALT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Norcross, GA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1133416
- Former names
- PRO PHARMACEUTICALS INC
Frequently asked questions
What exchange is Galectin Therapeutics Inc listed on?
Galectin Therapeutics Inc trades on the Nasdaq under the ticker symbol GALT.
What industry is Galectin Therapeutics Inc in?
Galectin Therapeutics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Galectin Therapeutics Inc headquartered?
Galectin Therapeutics Inc's business address on file with the SEC is in Norcross, GA.
When does Galectin Therapeutics Inc's fiscal year end?
Galectin Therapeutics Inc's fiscal year ends on December 31.